Baker McKenzie advised Cassiopea SpA on the deal.
Cassiopea SpA completed a rights offering, 750,000 new registered shares, corresponding to 7.5% of Cassiopea’s share capital before the rights offering, were offered to existing shareholders at an offer price of €31 per share.
Cassiopea SpA is a clinical stage specialty pharmaceutical company focused on developing and commercializing dermatology products.
The Baker McKenzie team included Dr. Matthias Courvoisier (Picture), Ludovico Rusconi (Milan), Beau Visser, Vinzenz Sutter and Ladislas von Sury d’Aspremont.
Involved fees earner: Matthias Courvoisier – Baker McKenzie; Ludovico Rusconi – Baker McKenzie; Vinzenz Sutter – Baker McKenzie; Beau Visser – Baker McKenzie; Ladislas von Sury d’Aspremont – Baker McKenzie;
Law Firms: Baker McKenzie;
Clients: Cassiopea SpA;